Assessing the benefits of digital adherence monitoring for sites and patients.
Bernard Vrijens
Advertisement
CEO & Scientific Lead, AARDEX Group
Articles by Bernard Vrijens
A look at some of the leading causes of study failure and explain how improving medication adherence could be the key to risk mitigation.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
Real-Time Continuous Trials Through the Lens of Risk-Based Quality Management: Why RBQM Is the Infrastructure RTCT Cannot Exist Without
3
What Needs to Happen Beyond the Clinical Trial Modernization Act
4
ACT Brief: Community Trial Access Technology, RBQM Infrastructure, and Digital Clone Use Cases
5